Pre-transfusion tests include ABO and RhD typing of the patient's red blood cells and an antibody screen with the patient's plasma. The latter is a method to detect clinically significant non-ABO antibodies to red cell antigens
Answer:
VO2
Explanation:
This should be the right answer.
Answer:
well since he is moving near his daughter and I'm assuming she's young, he could ask her to get those drugs and give them to her.
Answer:
Benign is a non- cancerous growth on the body. a malignant tumor is a cancerous tumor.
